Annual Drug Patent Expirations for IMPLANON
Implanon is a drug marketed by Organon Usa Inc and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.
This drug has twenty-four patent family members in twenty-one countries.
The generic ingredient in IMPLANON is etonogestrel. One supplier is listed for this compound. Additional details are available on the etonogestrel profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com